Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
about
β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling.The future of multiple sclerosis treatments.Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate.Precision Electrophile Tagging in Caenorhabditis elegans.
P2860
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dimethyl fumarate in the manag ...... ion and special considerations
@ast
Dimethyl fumarate in the manag ...... ion and special considerations
@en
Dimethyl fumarate in the manag ...... ion and special considerations
@nl
type
label
Dimethyl fumarate in the manag ...... ion and special considerations
@ast
Dimethyl fumarate in the manag ...... ion and special considerations
@en
Dimethyl fumarate in the manag ...... ion and special considerations
@nl
prefLabel
Dimethyl fumarate in the manag ...... ion and special considerations
@ast
Dimethyl fumarate in the manag ...... ion and special considerations
@en
Dimethyl fumarate in the manag ...... ion and special considerations
@nl
P2860
P356
P1476
Dimethyl fumarate in the manag ...... ion and special considerations
@en
P2093
Luca Prosperini
Simona Pontecorvo
P2860
P304
P356
10.2147/TCRM.S85099
P407
P577
2016-01-01T00:00:00Z